Related Sciences (RS) is a data science-driven drug discovery firm.RS invests in and leads the discovery of valuable preclinical medicines utilizing a specialized new model designed from the ground up to improve capital efficiency, operational scalability, and deliver superior risk-adjusted returns. RS uses a proprietary AI/ML platform to identify the best new opportunities for every disease, assembles large decentralized teams of field-leading researchers to guide world-class science, and then leads efficient, multi-modality drug discovery via preclinical-specialized staff and R&D platforms.The RS mission is to deliver a new biotech investment paradigm with a significantly improved risk-reward profile to accelerate the creation of transformative new medicines for patients, and to materially broaden the sector’s investor appeal.RS was founded by a multi-disciplinary team of drug discovery, data science, and private equity veterans who have built and led biotech companies worth billions and is backed by a luminary group of investors. www.related.vc

Co-inventor of the Fusogen gene therapy platform of Sana Biotechnology.

Research team lead responsible for co-inventing the Fusogen gene therapy technology, setting preclinical development strategy, and leading innovation research. The Fusogen platform at Cobalt Biomedicine became the lead gene therapy platform of Sana Biotechnology in January of 2019.